131 related articles for article (PubMed ID: 34020962)
21. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial.
Willcox M; Simpson C; Wilding S; Stuart B; Soilemezi D; Whitehead A; Morgan A; Wrixon E; Zhu S; Yao G; Webley F; Yan R; Bostock J; Bell M; Griffiths G; Leydon G; Little P; Butler C; Hay AD; Moore M
BMC Complement Med Ther; 2021 Jan; 21(1):48. PubMed ID: 33514367
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C
Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245
[TBL] [Abstract][Full Text] [Related]
23. Methylphenidate as Needed for Fatigue in Patients With Advanced Cancer. A Prospective, Double-Blind, and Placebo-Controlled Study.
Pedersen L; Lund L; Petersen MA; Sjogren P; Groenvold M
J Pain Symptom Manage; 2020 Nov; 60(5):992-1002. PubMed ID: 32464260
[TBL] [Abstract][Full Text] [Related]
24. A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study).
Hegerl U; Mergl R; Sander C; Dietzel J; Bitter I; Demyttenaere K; Gusmão R; González-Pinto A; Zorrilla I; Alocén AG; Sola VP; Vieta E; Juckel G; Zimmermann US; Bauer M; Sienaert P; Quintão S; Edel MA; Bolyos C; Ayuso-Mateos JL; López-García P; Kluge M
Eur Neuropsychopharmacol; 2018 Jan; 28(1):185-194. PubMed ID: 29174864
[TBL] [Abstract][Full Text] [Related]
25. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
[TBL] [Abstract][Full Text] [Related]
26. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
[TBL] [Abstract][Full Text] [Related]
27. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
[TBL] [Abstract][Full Text] [Related]
28. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
[TBL] [Abstract][Full Text] [Related]
29. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
30. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.
Ravindran AV; Kennedy SH; O'Donovan MC; Fallu A; Camacho F; Binder CE
J Clin Psychiatry; 2008 Jan; 69(1):87-94. PubMed ID: 18312042
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial.
Paulsen O; Klepstad P; Rosland JH; Aass N; Albert E; Fayers P; Kaasa S
J Clin Oncol; 2014 Oct; 32(29):3221-8. PubMed ID: 25002731
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
34. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Banerjee S; Hellier J; Romeo R; Dewey M; Knapp M; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
Health Technol Assess; 2013 Feb; 17(7):1-166. PubMed ID: 23438937
[TBL] [Abstract][Full Text] [Related]
35. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
[TBL] [Abstract][Full Text] [Related]
36. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
37. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Nutt JG; Carter JH; Carlson NE
Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
[TBL] [Abstract][Full Text] [Related]
38. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
[TBL] [Abstract][Full Text] [Related]
39. Managing fatigue in sarcoidosis - A systematic review of the evidence.
Atkins C; Wilson AM
Chron Respir Dis; 2017 May; 14(2):161-173. PubMed ID: 27507833
[TBL] [Abstract][Full Text] [Related]
40. A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities.
McNamara R; Randell E; Gillespie D; Wood F; Felce D; Romeo R; Angel L; Espinasse A; Hood K; Davies A; Meek A; Addison K; Jones G; Deslandes P; Allen D; Knapp M; Thapar A; Kerr M
Health Technol Assess; 2017 Aug; 21(47):1-92. PubMed ID: 28857740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
